Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Carlo Sistilli is Director at Edesa Biotech. OQRO lists 1 transaction filed with the SEC under this name, the latest on May 30, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Carlo Sistilli reported holding 49,417 shares of Edesa Biotech (EDSA), worth about $93K at the last close of $2 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Edesa Biotech EDSA | 49,417 | 49K direct | $2 | $93K | May 27, 2026 |
Is this Carlo Sistilli’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Carlo Sistilli bought shares on the open market in 2020, and has not bought since 2020.
Carlo Sistilli reported 1 open-market purchase and 0 sales since 2020; purchases in 2020.
| Year | Bought | Sold |
|---|---|---|
| 2020 | $10K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Edesa BiotechEDSA
May 27, 202619Kdisclosed May 30
DetailsOfficial recordCarlo Sistilli reported 1 open-market purchase and 0 sales here, 2020.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated May 27, 2026, Carlo Sistilli reported holding 49,417 shares of Edesa Biotech (EDSA). At the last close of $2 on Nov 16, 2026, that is about $93K. This is the stake disclosed in filings, not a net worth.
Carlo Sistilli bought shares on the open market in 2020, and has not bought since 2020.
In SEC filings since 2020: the latest open-market purchase is from 2020; no open-market sale is on record.
Edesa Biotech (EDSA), from 2020 to 2020: 1 purchase and 0 sales.